Site and histology
Ovarian masses predominated (n=106; 48.6%), reflecting the
proportionately larger number of female patients, followed by
extragonadal sites (EG) (n=72; 33%) and lastly testicular masses (n=40;
18.3%). Yolk sac tumours were most common (n=119; 54.6%), followed by
dysgerminomas (n=53; 24.3%), mixed germ cell tumours (n=32; 13.8%),
embryonal carcinomas (n=8; 3.7%), seminomas (n=4; 1.8%) and
choriocarcinomas (n=2; 0.9%).